Proteus Digital Health Stock
Digital health products
Sign up today and learn more about Proteus Digital Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Proteus Digital Health Stock
Proteus Digital HealthÂź is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when theyâve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.
Investors
Funding History
May 2001 | $750K |
---|---|
December 2003 | $11.0M |
May 2006 | $34.0M |
October 2008 | $32.1M |
December 2009 | $35.0M |
May 2013 | $85.8M |
July 2014 | $201M |
April 2016 | $111M |
Management
Co-Founder & Chief Executive Officer
Andrew Thompson
Co-Founder & Chief Medical Officer
George Savage, M.D.
Co-Founder & Chief Technologist
Mark Zdeblick, Ph.D.
Chief Platform Officer
David O'Reilly
Press
news - Feb, 26 2024
A Growing List Of Unicorns Havenât Raised Funding For 3-Plus Yearspharmiweb - Jul, 29 2021
Digital Pills Market To Witness Massive Growth | Competitive Outlook Proteus Digital Health., Ostuka Holdings Co., Ltd., 2morrow Inc. Pure Tech, Teladoc Health, Incpharmiweb - Feb, 18 2021
IoT In Healthcare Market Size anticipates 19.8% CAGR between 2020-2027medcitynews - Jan, 15 2021
âSmart pillâ startup etectRx strikes partnership with Pear Therapeuticsfiercehealthcare - Sep, 5 2020
From big deals to bankruptcy, a digital health unicorn falls short. Here's what other startups can learn from Proteus